PGM
MED icon

Parian Global Management’s Medifast MED Stock Holding History

Parian Global Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-52,900
Closed -$5.48M – 52
2019
Q3 		$5.48M Buy
+52,900
New +$5.69M 2.49% 14

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parian Global Management's MED Position: Q4 2019 in Review

Parian Global Management sold out of Medifast (MED) in Q4 2019, closing a stake of 52,900 shares — an estimated $5.48M sold.

Parian Global Management first reported a position in MED in Q3 2019 and held it in 1 quarter. The position peaked at $5.48M in Q3 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Parian Global Management reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Parian Global Management sold 52,900 Medifast shares in Q4 2019, an estimated $5.48M.
  • Parian Global Management first reported a position in Medifast in Q3 2019 and held it in 1 quarter.
  • Parian Global Management's Medifast position peaked at $5.48M in Q3 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Parian Global Management's 13F filing for Q4 2019, filed 14 Feb 2020.